Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis Carla RognoniMonia MarchettiNicola Lucio Liberato OriginalPaper 28 June 2014 Pages: 149 - 154
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism Simon ManthaJack Ansell OriginalPaper 03 July 2014 Pages: 155 - 165
Home treatment of patients with small to medium sized acute pulmonary embolism J. E. ElfJ. JögiM. Bajc OriginalPaper 19 June 2014 Pages: 166 - 172
Continuation of venous thromboembolism prophylaxis after hospital discharge into the outpatient setting: the ACCEPT study Sebastian M. SchellongJürgen KaiserPeter Bramlage OriginalPaper 05 July 2014 Pages: 173 - 178
Platelet–lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome Handan Inonu KoseogluFatih AltunkasOsman Demir OriginalPaper 08 July 2014 Pages: 179 - 185
The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome Travis R. SextonEric L. WallaceSusan S. Smyth OriginalPaper Open access 12 October 2014 Pages: 186 - 195
Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent Mohamed Mahmoud El-SeweidyMervat El-Sayed AskerMohamed Ahmed Abdallah OriginalPaper 12 November 2014 Pages: 196 - 202
Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma Jung Rae ChoDominick J. Angiolillo OriginalPaper 28 August 2014 Pages: 203 - 208
Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months Bin ZhangNing YangCong Gao OriginalPaper 18 June 2014 Pages: 209 - 214
A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis Jizheng QinHongwei LiangQing Jiang OriginalPaper 23 September 2014 Pages: 215 - 221
Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials Larry R. Jackson IIEric D. PetersonKevin Thomas OriginalPaper 02 November 2014 Pages: 222 - 227
Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing Zhenqi LiaoShaoguang FengGuoqing Zhang OriginalPaper 25 June 2014 Pages: 228 - 234
Recombinant activated factor VII in clinical practice: a 2014 update Massimo FranchiniSilvia CrestaniCarlo Bonfanti ReviewPaper 12 July 2014 Pages: 235 - 240
Calcific embolization with infective endocarditis involving the posterior mitral leaflet in a patient with underlying hypertrophic obstructive cardiomyopathy Navneet LatherKyle NiziolekDavid M. Harris Report 17 July 2014 Pages: 241 - 244
Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma Maeve P. CrowelyShane QuinnSusan I. O. Shea OriginalPaper 01 October 2014 Pages: 245 - 249
Erratum to: Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma Maeve P. CrowleyShane QuinnSusan I. O’Shea Erratum 15 November 2014 Pages: 250 - 250
Aortic thrombosis successfully treated with local recombinant tissue plasminogen activator in a newborn Georgia Sarquella-BrugadaJavier Rodríguez-FanjulFredy Prada Martínez Report 29 June 2014 Pages: 251 - 253
Right atrial thrombosis associated with hemodialysis catheter: first description of recurrence in a poorly understood problem Luis AsmaratsCarlos Fernández-PalomequeArmando Bethencourt Report 17 July 2014 Pages: 254 - 257
Primary venous thromboembolism prophylaxis in patients with solid tumors A. CasanegraA. MansfieldA. Tafur Reply to the Letter 09 December 2014 Pages: 258 - 259
Primary thromboprophylaxis in patients with solid cancers Nay Min Tun Letter to the Editor 18 September 2014 Pages: 260 - 261
